Related Experiment Video
Updated: Aug 17, 2025
Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors
Published on: August 18, 2016
Delineating the tumour microenvironment response to a lipid nanoparticle formulation
Jessica Ngai1, Presley MacMillan2, Benjamin R Kingston3
1Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, Ontario M5S 3E5, Canada; Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, Ontario M5S 3E1, Canada; Institute of Biomedical Engineering, University of Toronto, Rosebrugh Building, 164 College Street, Toronto, Ontario M5S 3G9, Canada.
Liposomal doxorubicin (Doxil) demonstrates greater overall cancer cell death than free doxorubicin, but with delayed effects. Nanoparticle behavior significantly impacts cancer therapy effectiveness.
Area of Science:
- Oncology
- Nanomedicine
- Pharmacology
Background:
- Nanoparticles offer potential advantages over free drugs in cancer therapy, including reduced toxicity and improved tumor accumulation.
- However, the precise cellular-level therapeutic value of nanoparticle drug delivery systems remains incompletely understood.
- This study investigates the cytodistribution and efficacy of a liposomal formulation versus its small molecule counterpart.
Purpose of the Study:
- To compare the cellular-level efficacy and cytodistribution of Doxil (liposomal doxorubicin) and doxorubicin (free drug) in a 4T1 breast cancer model.
- To delineate the differences in cell killing kinetics and tumor microenvironment repopulation between the two formulations.
- To establish the influence of nanocarrier behavior on therapeutic outcomes.
Main Methods:
- Cytodistribution analysis of doxorubicin and Doxil in 4T1 breast cancer tumors.
- Assessment of cancer cell, macrophage, and neutrophil killing by both formulations.
- Monitoring of tumor cell and immune cell repopulation during the relapse phase.
Main Results:
- Doxil resulted in greater overall cancer cell, macrophage, and neutrophil death compared to doxorubicin.
- Doxil exhibited slower uptake kinetics, requiring particle degradation for drug release and cell killing.
- Macrophages and neutrophils repopulated faster in Doxil-treated tumors during relapse compared to cancer cells.
Conclusions:
- The fate and behavior of nanocarriers critically influence their effectiveness in cancer therapy.
- Nanoparticle formulation significantly alters cell killing dynamics and tumor microenvironment interactions.
- Further research into nanoparticle-tumor microenvironment interactions is essential for designing targeted cancer nanotherapeutics.
